Srivatsan Murali

Director

While the demand is moving toward therapies that deliver clinical precision alongside patient com­fort, India’s topical and transdermal medication manufacturing market is in the midst of a structural shift. Faster onset, reduced systemic exposure, and targeted ac­tion now shape the development of various products.

At the same time, end-users expect formulations that absorb quickly, feel cosmetically elegant, and remain non-irritant, while manufacturers navigate tighter regulatory expecta­tions around stability, skin safety, and process validation.

Within this evolving landscape, brands face mounting execution challenges. Topical formulations require a delicate balance between penetration, stability, and sensorial performance, where even minor formulation changes can alter outcomes.

Regulatory requirements add further pressure, with documentation now demanding robust proof of efficacy, skin compatibility, and reproducible manufacturing processes.

It is at this intersection of market evolution and formu­lation challenge that Dollar Medicine positions itself. Act­ing as a technical mentor rather than just a manufacturer, the company enables faster, safer, and compliant pathways to market, helping clients translate complex topical science into reliable, patient-ready products.

The Guiding Vision

Dollar Medicine kick started with a mission to make high-performance topical medication manufacturing accessible, ethical, and globally competitive. Notably, the company is known for carrying a legacy of over 80 years through trusted brands such as Hadensa, used in hemorrhoid care, and Lichensa, developed for fungal infections and cracked skin.

Over time, operations evolved into a fully compliant GMP and Schedule M facility with scalable batch capacities across gels, creams, ointments, and lotions. “We operate at the intersection of evolving patient expectations and complex formulation science, enabling brands to translate topical innovation into safe, compliant, and patient-ready therapies,” states Srivatsan Murali, Director at Dollar Medicine.

Today, the company has on-boarded major Indian pharmaceutical and healthcare brands and launched multiple successful dermatology and wound-care products. Additionally, it has expanded its presence across India, South-East Asia, and Africa.

Forging its Own Path

The company offers a diverse portfolio of topical and transdermal formulations across dermatology, wound care, pain management, cosmeceuticals, hygiene, and chronic-care therapies. Additionally, the company supports brands through end-to-end formulation development, analytical method creation, in-house stability testing, skin-irritation assessment, and complete technical dossier preparation, and all the Manufacturing operations comply with world-class GMP and Schedule M standards.

Notably, the product range includes nanocrystalline silver gels, antifungal and antibacterial creams, anti-inflammatory gels, moisturizing & barrier-repair formulations, medicated ointments, diabetic foot care solutions, and pre- and post-procedure dermal applications.

In total, the company follows a formulation-first philos­ophy. Each formulation uses skin-friendly base technolo­gies, penetration-optimized systems, and tailored rheology profiles to enhance efficacy and patient acceptance. In fact, controlled-release designs support sustained action in sen­sitive indications.

Furthermore, the team engineers every product around the molecule’s behavior on the skin rather than relying on standardized bases.

Engineering Excellence

Dollar Medicine operates with a multidisciplinary team of formulation scientists, analytical chemists, quality specialists, microbiologists, regulatory experts, and production technologists. This team brings decades of hands-on industry experience, with senior formulators having developed over 150 to 200 topical products. On the whole, the team culture emphasizes precision, transparency, and scientific curiosity.

In addition, quality is built into each stage of development rather than assessed only at the end. Most importantly, clients value the team’s responsiveness, technical clarity, and problem-solving approach, which strengthen confidence and support long-term partnerships.

The Technical Edge

The company follows a clear R&D philosophy: science first, speed second, with integrity intact. The team continuously evaluates penetration enhancers, gelling agents, nanoparticle systems, and skin-safe preservatives to remain aligned with evolving consumer and regulatory expectations.

Innovation focuses on proprietary base systems for improved dermal absorption, advanced rheology tools for sensory optimization, and iterative prototyping that allows rapid evaluation of multiple variants. Notably, regulatory-aligned development ensures compliance with the latest safety norms. In total, the innovation pipeline prioritizes clean formulations, natural derivative excipients, and long-acting delivery platforms.

With respect to Infrastructure upgrades, the company has introduced automated filling lines, digital manufacturing monitoring, and advanced quality control instrumentation.

A Robust Future Roadmap

Dollar Medicine’s path ahead focuses on becoming a specialist innovation hub for topical therapy. Planned developments include nano-structured gels, extended-release dermal systems, and biomaterial-based wound dressings, along with a dedicated R&D centre for penetration science and skin-mimicking evaluations.

Additionally, the company plans entry into chronic seg­ments such as cardiometabolic care, chronic orthopaedic management, and supplements. International regulatory filings will support expansion into semi-regulated and reg­ulated markets. Capacity enhancements will address rising demand in cosmeceutical and clinical dermatology prod­ucts.

While investments in digital quality systems and predictive analytics will strengthen process optimization, collaborative development programs with healthcare startups and global partners will drive co-innovation. In total, Dollar Medicine aims to evolve into a strategic formulation and innovation partner for global brands.